ArticleFrontiers in immunology2025

CPLX1 is a novel prognostic biomarker in CRC correlating with immunotherapy resistance and ferroptosis.

Canyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.